Canntab Therapeutics Limited (OTCMKTS:CTABF) is moving in a range after offering an update regarding recent deliveries in Australia and Ontario. Canntab delivered its first supply of 5 mg THC pills to Ontario Cannabis Store on January 7, 2022. It also delivered its second CBD and THC tablets shipment to Australia in early December 2021.
On Monday, CTABF stock ended flat at $0.5513 with more than 4 shares, compared to its average volume of 1.3K shares. The stock has moved within a range of $0.5513 – 0.5513 after opening trading at $0.5513.
Canntab Delivers 1st Shipment To The Ontario Cannabis Store And 2nd Shipment To Australia
The company’s CEO Larry Latowsky stated that the initial delivery to the Ontario Cannabis Stores marks the start of a growing and productive relationship. He said that the product would be accessible to all OCS locations for purchase as well as online through their website.
Most importantly, Canntab will support distribution and sales with point of sale programs and marketing materials to educate budtenders in Ontario about Cannatab’s unique products and patented delivery system. Latowsky also explained that the second shipment to Australia is a sign of acceptance of the company’s products in Australia. So in the coming weeks, investors should keep an eye on CTABF.
Larry Latowsky, Chief Executive Officer of Canntab commented “Our initial delivery to the OCS is a first for us and marks the beginning of a productive and growing relationship. Our product will be available to all Ontario Cannabis stores for purchase in addition to being available for sale via the OCS website. We will support the sales and distribution of the Canntab brand with strong marketing materials and point of sale programs, engaging expert teams to educate all Ontario budtenders about the unique nature of Canntab’s products and its patented delivery system. We are encouraged as well with our future listing of CBD products which will ship to the OCS in early spring 2022.”
CTABF stock is trading above the 10-Day and 20-Day Moving averages of $0.5103 and $0.5259 respectively. However, the stock is trading below the 200-Day moving average of $0.6463.